NNZ-2566: Phase IIa start

In mid-2008, NEU will begin a double-blind, placebo-controlled Phase IIa trial in 100 patients to evaluate a single bolus injection of 20 mg/kg NNZ-2566 followed by an IV infusion of 6 mg/kg/hour NNZ-...